GlucoTrack Inc.

08/19/2026 | Press release | Distributed by Public on 08/19/2026 07:01

Proxy Results (Form 8-K)

Item 5.07. Submission of Matters to a Vote of Security Holders.

Summary of Proposals Submitted to Stockholders

On August 18, 2026, Glucotrack, Inc. (the "Company") held its 2026 annual meeting of stockholders (the "Annual Meeting"). At the Annual Meeting, the following proposals were submitted to the stockholders of the Company, as set forth in the Company's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on July 17, 2026:

Proposal 1: The election of six directors, each to serve until the 2027 annual meeting of stockholders and until his or her successor is duly elected and qualified.
Proposal 2: The approval, on an advisory basis, of the 2025 executive compensation of the Company's named executive officers ("Say-on-Pay").
Proposal 3: The ratification of the appointment of CBIZ CPAs P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.
Proposal 4: The approval of one or more amendments to the Company's certificate of incorporation (as amended, the "Certificate of Incorporation") to effect one or more reverse stock splits of the Company's common stock, par value $0.001 per share (the "Common Stock"), at an aggregate ratio not to exceed one-for-thirty (the "Reverse Stock Split").
Proposal 5: The approval of a proposed warrant inducement, including the repricing of certain existing warrants and the issuance of new inducement warrants to the holders of such existing warrants and the issuance of shares of Common Stock upon exercise thereof, for purposes of complying with Nasdaq Listing Rule 5635(d) (the "Warrant Inducement").

Voting Results

On the record date, there were 7,719,121 shares of Common Stock issued and outstanding. Of the 7,719,121 votes that were eligible to be cast by the holders of the Common Stock at the Annual Meeting, 2,786,974 votes, or approximately 36.10% of the total, were represented at the meeting in person or by proxy, constituting a quorum. The number of votes cast for, against or withheld, as well as abstentions and broker non-votes, if applicable, in respect of each such matter is set forth below:

Proposal 1: Election of Directors.

The Company's stockholders elected the following directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified. The votes regarding the election of these directors were as follows:

Director Nominee Votes For Votes Against Abstentions Broker Non-Votes
Andrew K. Balo 960,882 75,038 83,448 1,667,606
Victoria Carr-Brendel 960,826 75,088 83,454 1,667,606
Erin Carter 960,573 75,278 83,517 1,667,606
Erik Emerson 961,363 74,550 83,455 1,667,606
Paul V. Goode 934,050 134,410 50,908 1,667,606
Luis Malavé 960,650 75,211 83,507 1,667,606
GlucoTrack Inc. published this content on August 19, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on August 19, 2026 at 13:02 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]